-
January 2026: This Month in Huntington’s Disease Research
Latest News
-
The brain in Huntington's disease: greater than the sum of its parts?
An important new study asks the question: what parts of the brain might need most help in HD?
-
NUB1: enhancing clearance to decrease mutant huntingtin
NUB1 increases mutant huntingtin removal from cells, reducing the toxic effects of HD in fruit flies
-
Could HD be caused by amino acid deficiency?
Does a specific amino acid deficiency contribute to the development of HD?
-
Raptor announces results of cysteamine trial for Huntington's disease
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
-
Sleep, cilia and HD
New studies shed some light on the function of sleep in animals, with interesting implications for HD research
-
Huntington's Disease Therapeutics Conference 2014: day 3
Biomarkers and preparing for trials: the third & final day of the 2014 Huntington's Disease Therapeutics Conference
-
Huntington's Disease Therapeutics Conference 2014: day 2
Cells, circuits and systems: day 2 of the 2014 HD Therapeutics conference
-
Huntington's Disease Therapeutics Conference 2014: day 1
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.
-
Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?
-
Does high-dose creatine "slow the onset" of Huntington's Disease?
A new study claims that high-dose creatine "slows the onset of Huntington Disease". How much hope and how much hype?
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
